Item Type | Name |
Concept
|
Analgesics, Opioid
|
Academic Article
|
Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
|
Academic Article
|
Morphine and codeine concentrations in human urine following controlled poppy seeds administration of known opiate content.
|
Academic Article
|
Monitoring Prenatal Exposure to Buprenorphine and Methadone.
|
Academic Article
|
Oral fluid testing for drugs of abuse.
|
Academic Article
|
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids.
|
Academic Article
|
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.
|
Academic Article
|
Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes.
|
Academic Article
|
Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid.
|
Academic Article
|
Concentrations of methadone in breast milk and plasma in the immediate perinatal period.
|
Academic Article
|
Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry.
|
Academic Article
|
Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
|
Academic Article
|
Respiratory effects of oral mitragynine and oxycodone in a rodent model.
|
Academic Article
|
Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
|
Academic Article
|
Simultaneous quantification of nicotine, opioids, cocaine, and metabolites in human fetal postmortem brain by liquid chromatography tandem mass spectrometry.
|
Academic Article
|
Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients.
|
Academic Article
|
Urine drug testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometry.
|
Academic Article
|
Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry.
|
Academic Article
|
Miniaturized extraction method for analysis of synthetic opioids in urine by microextraction with packed sorbent and liquid chromatography-tandem mass spectrometry.
|
Academic Article
|
Maternal Buprenorphine Maintenance and Lactation.
|
Academic Article
|
Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration.
|
Academic Article
|
Oral Fluid Drug Testing: Analytical Approaches, Issues and Interpretation of Results.
|
Academic Article
|
Erratum to "Miniaturized extraction method for analysis of synthetic opioids in urine by microextraction with packed sorbent and liquid chromatography-tandem mass spectrometry" [J. Chromatogr. A 1624 (2020) 461241].
|
Academic Article
|
A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications.
|
Academic Article
|
Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.
|
Academic Article
|
Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation.
|
Academic Article
|
Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry.
|